| Description | 1
Day Price Change %  | Market Cap | P/E | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | 1.27 | 1935.9B | 54.96 | 12.60 | 2.60 | NA | 7.98 | 12.49 | 67.81 |
| Industry: Drug Manufacturers - Major (More Info) | 1.21 | 975.4B | 16.40 | 17.30 | 3.67 | NA | 8.24 | 18.40 | 86.70 |
| Companies | |||||||||
| Omeros Corporation (OMER) | -6.00 | 20.8M | NA | NA | NA | NA | NA | NA | -6.55 |
| iBio, Inc. (IBPM.OB) | -5.05 | 26.3M | NA | NA | NA | NA | 5.00 | NA | -127.68 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | -4.67 | 66.2M | NA | -110.12 | NA | NA | 6.54 | NA | -37.66 |
| China Aoxing Pharmaceutical Co (CAXG.OB) | -4.00 | 110.0M | NA | -10.83 | NA | NA | 4.04 | -77.00 | -40.78 |
| Evotec AG (EVTC) | -2.55 | 665.0M | NA | -53.24 | NA | NA | NA | -35.16 | NA |
| Abbott Laboratories (ABT) | -0.95 | 82.2B | 14.39 | 27.52 | 3.00 | NA | 3.85 | 19.07 | 43.05 |
| Javelin Pharmaceuticals, Inc. (JAV) | -0.68 | 93.2M | NA | -317.53 | NA | NA | NA | NA | -29.43 |
| Spectrum Pharmaceuticals, Inc. (SPPI) | -0.63 | 229.8M | NA | -30.57 | NA | NA | 1.85 | -118.14 | 419.89 |
| Keryx Biopharmaceuticals Inc. (KERX) | -0.43 | 128.2M | 9.66 | 64.26 | NA | NA | 3.66 | NA | -98.38 |
| Merck & Co. Inc. (MRK) | -0.11 | 76.8B | 9.56 | 37.90 | 4.20 | NA | 3.35 | 56.60 | 18.32 |
| Aceto Corp. (ACET) | 0.00 | 129.8M | 25.81 | 3.55 | 3.80 | NA | 0.90 | 1.42 | -16.14 |
| Callisto Pharmaceuticals, Inc. (CLSP.OB) | 0.00 | 12.7M | NA | NA | NA | NA | NA | NA | -17.71 |
| Quick-Med Technologies Inc. (QMDT.OB) | 0.00 | 20.3M | NA | NA | NA | NA | NA | NA | -50.54 |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | 0.00 | 0.8M | NA | NA | NA | NA | NA | NA | 3.06 |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.9M | NA | NA | NA | NA | NA | NA | -423.37 |
| Winston Pharmaceuticals, Inc. (WPHM.OB) | 0.00 | 48.0M | NA | -129.03 | NA | NA | 47.69 | -200.42 | -81.06 |
| Znomics, Inc. (ZNOM.OB) | 0.00 | 0.6M | NA | -260.11 | NA | NA | 3.33 | -185.00 | -1.83 |
| Myriad Pharmaceuticals, Inc. (MYRX) | 0.38 | 131.1M | NA | -76.32 | NA | NA | 0.72 | NA | -24.43 |
| Eli Lilly & Co. (LLY) | 0.57 | 42.3B | NA | -1.83 | 5.40 | NA | 4.27 | 16.93 | 204.39 |
| Johnson & Johnson (JNJ) | 0.61 | 173.0B | 13.69 | 26.58 | 3.10 | NA | 3.43 | 22.18 | 46.78 |
| Pfizer Inc. (PFE) | 0.93 | 149.5B | 15.39 | 12.12 | 3.50 | NA | 2.26 | 24.77 | 59.76 |
| AP Pharma Inc. (APPA) | 1.09 | 29.2M | NA | -182.47 | NA | NA | 21.14 | NA | -11.00 |
| Impax Laboratories Inc. (IPXL) | 1.24 | 707.8M | 29.41 | 14.25 | NA | NA | 3.90 | 10.29 | 38.06 |
| AstraZeneca plc (AZN) | 1.29 | 65.8B | 9.12 | 40.66 | 2.60 | NA | 3.39 | 25.79 | 40.70 |
| GlaxoSmithKline plc (GSK) | 1.47 | 106.8B | 13.09 | 58.25 | 4.70 | NA | 6.84 | 19.75 | 35.52 |
| WuXi PharmaTech (Cayman) Inc. (WX) | 1.73 | 1.0B | NA | -2.83 | NA | NA | 3.96 | 20.45 | NA |
| Bristol-Myers Squibb Co. (BMY) | 2.41 | 49.6B | 12.96 | 27.57 | 5.10 | NA | 3.42 | 17.61 | 39.80 |
| Sanofi-Aventis (SNY) | 2.52 | 100.8B | NA | NA | 3.80 | NA | NA | 28.68 | NA |
| Novartis AG (NVS) | 3.05 | 124.3B | 16.39 | 14.59 | 3.20 | NA | 2.33 | 18.58 | 55.03 |
| Rigel Pharmaceuticals, Inc. (RIGL) | 3.47 | 417.2M | NA | -91.80 | NA | NA | 3.20 | NA | -26.17 |
| CPEX Pharmaceuticals, Inc. (CPEX) | 3.59 | 29.4M | NA | -9.94 | NA | NA | 1.27 | -17.61 | -22.36 |
| Skystar Bio Pharmaceutical Com (SKBID) | 4.35 | 83.6M | 6.95 | 20.91 | NA | NA | 1.64 | 41.85 | -15.62 |
| Avigen Inc. (AVGN) | 5.63 | 44.8M | NA | -25.69 | NA | NA | 1.19 | NA | -19.29 |
| Novogen Limited (NVGN) | 8.89 | 50.0M | NA | -69.63 | NA | NA | 2.25 | -208.88 | -14.15 |
| Neurologix Inc. (NRGX.OB) | 9.09 | 16.7M | NA | -83.57 | NA | NA | 2.08 | NA | -8.15 |
| GeoPharma Inc. (GORX) | 10.91 | 11.8M | NA | -53.74 | NA | NA | 1.78 | -73.18 | 4.31 |
| China Pharma Holdings, Inc. (CPHI) | NA | NA | NA | 27.37 | NA | NA | NA | 46.15 | NA |
| HST Global, Inc. (HSTC.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Medizone International Inc. (MZEI.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |